Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › SC › Lexington › NPI 1043858996
Lab

M Holdings LLC

M Holdings LLC was paid $355K by Medicaid between Mar 2021 and Jan 2023, across 11 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 42% of everything it billed.

33Billing provider infoM HOLDINGS LLC
LEXINGTON, SC 29072
33aNPI1043858996assigned 12/11/2019
28Total paid$355K
24GClaims4,955
24DCodes billed11
24AFirst – last monthMar 2021 – Jan 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in South Carolina

Rank by total paid#21 of 39
Median peer was paid$403K
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202137$1K
20224,889$352K
202329$2K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 42% 1,185 1,052 $148K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 16% 807 675 $58K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 13% 861 731 $47K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 12% 1,543 1,325 $43K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 8.0% 199 184 $28K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 5.3% 83 76 $19K
87428 1.5% 92 84 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.1% 132 120 $4K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 16 15 $2K
0012A <1% 18 18 $665.04
0011A <1% 19 19 $646.15

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMANNING, JAMES (OWNER)
Same official

Other billing entities under MANNING, JAMES

Full network →
ProviderLocationPaid
My LabLexington, SC$1.31M
City of Auburn HillsAuburn Hills, MI$873K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.